Physician profile
Kelley Arcement
NPI 1174983506
$853.42
in general payments reported to CMS, 2019-2025
14 companies · $97.62 in 2025
The $97.62 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.61 · 2022: $320 · 2023: $306 · 2024: $107 · 2025: $97.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.81 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $266.69 | 2022-2023 | Opzelura |
| Merck Sharp & Dohme LLC | $80.91 | 2022-2023 | M-M-R II, Vaxneuvance, Vaxelis |
| Cranial Technologies, INC | $73.23 | 2023-2025 | Doc Band |
| Corium, LLC | $68.56 | 2022-2024 | Azstarys |
| Tris Pharma INC | $61.65 | 2022-2025 | Dyanavel Xr |
| Pfizer INC. | $54.95 | 2022-2024 | |
| Neos Therapeutics, LP | $52.14 | 2022-2023 | Cotempla Xr-Odt |
| Ars Pharmaceuticals Operations, INC. | $51.51 | 2025 | Neffy |
| Ironshore Pharmaceuticals INC. | $38.56 | 2022-2023 | Jornay Pm |
| Sanofi Pasteur INC. | $30.31 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.61 | 2021 | |
| Kaleo, INC. | $22.55 | 2023 | Auvi-Q |
| Collegium Pharmaceutical, INC. | $16.37 | 2025 | Jornay Pm |
| Aytu Biopharma, INC. | $13.38 | 2024 | Karbinal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelley Arcement listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.